Clinical Trials Directory

Trials / Completed

CompletedNCT00572403

Risk Factors Contributing to the Development of Microalbuminuria

Risk Factors Contributing to the Development of Microalbuminuria Over a 5 Year Period

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

This research project will look at the relationship between baseline variables, and the new onset of microalbuminuria and the response to treatment with an angiotensin receptor blocker, losartan, in a cohort of 246 early hypertensives and normotensives who are being brought back for a 4-5 year follow up visit as part of a continuing project. We hypothesize that the new onset of microalbuminuria is associated with higher blood pressure levels at baseline and 1 year as well as being associated with elevated left ventricular mass index. The rate of new onset microalbuminuria in non-diabetics is not established and this prospective study will provide data.

Detailed description

The primary objective of this research project is to determine risk factors related to the development of microalbuminuria. The secondary objective is to determine whether uric acid levels at the final visit are correlated with the onset of microalbuminuria. Of participants returning for a 4-5 year follow up visit as part of a continuing project, we will examine the proportion that have developed microalbuminuria. Subjects found to have microalbuminuria will be offered therapy with the ARB losartan and will be followed at three months to determine if there has been a reduction in levels.

Conditions

Timeline

Start date
2007-12-01
Completion
2008-04-01
First posted
2007-12-13
Last updated
2011-03-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00572403. Inclusion in this directory is not an endorsement.